Please ensure Javascript is enabled for purposes of website accessibility

US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill

49 minutes ago

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

17 hours ago

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

17 hours ago

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

19 hours ago

Will Valadao Spoil Trump’s Plan for July 4th ‘Big Beautiful Bill’ Signing?

20 hours ago

Shaver Lake and Reedley 4th of July Shows Are Wednesday. Who Else Is Celebrating?

23 hours ago

Elon Musk Says Senate Bill Would Destroy Jobs and Harm US

23 hours ago

Israel Strikes Pound Gaza, Killing 60, Ahead of US Talks on Ceasefire

1 day ago
Fighting COVID-19: 'Project Lightspeed' Vaccine Aims for April Testing
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
March 27, 2020

Share

Germany-based BioNTech is working with Pfizer Inc. to develop a potential COVID-19 vaccine. The collaboration aims to accelerate the development of BioNTech’s potential COVID-19 mRNA vaccine program, BNT162, which is expected to enter clinical testing by the end of April.

Editor’s Note: GV Wire is contacting companies around the world working on medical advancements to combat the COVID-19 pandemic. This article begins an ongoing series about efforts to defeat the coronavirus.
In an email exchange, a member of BioNTech communications teams, Laura Mittmann, answered these questions:

What’s Happening With Your Trial?

At the beginning of 2019, as evidence of the danger of a COVID-19 pandemic was growing, we initiated an internal R&D effort to develop a vaccine to induce immunity and prevent the COVID-19 infection. We named our internal efforts “Project Lightspeed.”

The resulting product candidate, BNT162, is a potential first-in-class mRNA vaccine against COVID-19.

What Are the Next Steps?

The next step in the development process is to initiate clinical testing for BNT162, pending approval from the regulatory agencies, as part of a global clinical development program in Europe, the United States, and China.
We are accelerating operational plans to manufacture the vaccine for clinical trials along with our partner, Polymun, at our state-of-the-art GMP-certified mRNA manufacturing facilities in Europe.

Where Do You See This Going in Coming Months?

We are committed to working as quickly as possible internally and with our partners to advance BTN162 with the goal of saving lives. That means we will continue to follow the regulatory guidelines and rules to ensure a safe and effective vaccine.

“It is important to remember that this is not a competitive race. We, together with all companies, research institutes, and governments, represent a global effort to battle a pandemic and save lives.” — BioNTech spokeswoman Laura Mittmann
Like any other pharmaceutical product, a potential vaccine has to go through stringent clinical testing and must be manufactured to high standards (termed “GMP” or good manufacturing practice) consistently and reliably.
We received German regulatory authority approval in 2011 to manufacture mRNA under GMP and have been producing mRNA for clinical testing since then. At this stage, safety is our biggest priority.
As soon as we possibly can, we will provide updates on the development process. It is important to remember that this is not a competitive race. We, together with all companies, research institutes, and governments, represent a global effort to battle a pandemic and save lives.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Dollar Gains Ground Against Major Peers After Better-Than-Expected US Jobs Data

DON'T MISS

A Path Forward on Immigration Reform That Strengthens America

DON'T MISS

France Shuts Schools, Italy Limits Outdoor Work as Heatwave Grips Europe

DON'T MISS

Powell Reiterates Fed Will Wait for More Data Before Cutting Rates

DON'T MISS

Visalia Police Investigate Morning Shooting Outside Bethlehem Center

DON'T MISS

Israeli Officials to Hold Ceasefire Talks in Washington Amid Military Escalation in Gaza

DON'T MISS

US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill

DON'T MISS

Trump Escalates Feud With Musk, Threatens Tesla, SpaceX Support

DON'T MISS

Clovis Police Seek Public’s Help in Finding Missing 82-Year-Old Woman

DON'T MISS

Fresno Woman Killed in Head-On Collision, CHP Investigating

UP NEXT

Will Valadao Spoil Trump’s Plan for July 4th ‘Big Beautiful Bill’ Signing?

UP NEXT

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

UP NEXT

US Supreme Court Preserves Key Element of Obamacare

UP NEXT

US Supreme Court Lets Parents Take Kids Out of Classes With LGBT Storybooks

UP NEXT

Bill Moyers, Broadcaster and LBJ’s White House Press Secretary, Dies at 91

UP NEXT

Tesla Executive, Elon Musk Confidant Leaves EV Maker, Bloomberg News Reports

UP NEXT

US Supreme Court Backs South Carolina Effort to Defund Planned Parenthood

UP NEXT

West Nile Virus Detected in Mosquitoes in Fresno County

UP NEXT

St. Agnes’ New Chief Medical Officer Is a Kidney Care Expert

UP NEXT

How a Birthday Boat Ride on Lake Tahoe Turned Tragic

Powell Reiterates Fed Will Wait for More Data Before Cutting Rates

15 minutes ago

Visalia Police Investigate Morning Shooting Outside Bethlehem Center

29 minutes ago

Israeli Officials to Hold Ceasefire Talks in Washington Amid Military Escalation in Gaza

47 minutes ago

US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill

49 minutes ago

Trump Escalates Feud With Musk, Threatens Tesla, SpaceX Support

52 minutes ago

Clovis Police Seek Public’s Help in Finding Missing 82-Year-Old Woman

15 hours ago

Fresno Woman Killed in Head-On Collision, CHP Investigating

16 hours ago

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

17 hours ago

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

17 hours ago

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports

17 hours ago

Dollar Gains Ground Against Major Peers After Better-Than-Expected US Jobs Data

NEW YORK – The U.S. dollar gained ground against major currencies including the yen and Swiss franc on Tuesday after data showed a bet...

5 minutes ago

U.S. dollar banknotes are seen in this illustration taken March 19, 2025. (Reuters/Dado Ruvic/Illustration)
5 minutes ago

Dollar Gains Ground Against Major Peers After Better-Than-Expected US Jobs Data

6 minutes ago

A Path Forward on Immigration Reform That Strengthens America

A tourist cools off in the Trocadero Fountain next to the Eiffel Tower as an early summer heatwave hits Paris, France, July 1, 2025. (Reuters/Tom Nicholson)
7 minutes ago

France Shuts Schools, Italy Limits Outdoor Work as Heatwave Grips Europe

Federal Reserve Chair Jerome Powell testifies before a House Financial Services Committee hearing on "The Semiannual Monetary Policy Report to the Congress," on Capitol Hill in Washington, D.C., U.S., June 24, 2025. (Reuters File)
15 minutes ago

Powell Reiterates Fed Will Wait for More Data Before Cutting Rates

A man was shot Tuesday, July 1, 2025, morning outside the Bethlehem Center in Visalia, and police are investigating the incident. (Visalia PD)
29 minutes ago

Visalia Police Investigate Morning Shooting Outside Bethlehem Center

Palestinians inspect the site of an Israeli strike on a house that took place on Monday, in Zawayda in the central Gaza Strip, July 1, 2025. (Reuters/Ramadan Abed)
47 minutes ago

Israeli Officials to Hold Ceasefire Talks in Washington Amid Military Escalation in Gaza

Documents tracking Senate votes are seen at the U.S. Capitol as Republican lawmakers struggle to pass U.S. President Donald Trump's sweeping spending and tax bill, on Capitol Hill in Washington, D.C., U.S., July 1, 2025. (Reuters/Nathan Howard)
49 minutes ago

US Senate Republicans Struggling to Unite on Trump’s $3.3 Trillion Tax-Cut Bill

President Donald Trump and Elon Musk attend a press conference in the Oval Office of the White House in Washington, D.C., U.S., May 30, 2025. (Reuters File)
52 minutes ago

Trump Escalates Feud With Musk, Threatens Tesla, SpaceX Support

Help continue the work that gets you the news that matters most.

Search

Send this to a friend